• Info
  • Insider Trading

Philip Astley-Sparke - Insider Trading & Ownership

Location
C/O Biovex Group, Inc., 34 Commerce Way, Woburn, MA
Summary
The estimated net worth of Philip Astley-Sparke is at least $11.4M dollars as of July 10, 2025. Philip Astley-Sparke is the Director of Replimune Group, Inc. and owns shares of Replimune Group, Inc. (REPL) stock worth about $11.3M. Philip Astley-Sparke is the Director of enGene Holdings Inc. and owns shares of enGene Holdings Inc. (ENGN) stock worth about $65K.
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
All Insider Reports
All Insider Reports

Notify me when Philip Astley-Sparke files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Philip Astley-Sparke

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
REPL Replimune Group, Inc. Director $11.3M -$260K -2.25% May 20, 2025
ENGN, ENGNW enGene Holdings Inc. Director $65K Jul 8, 2025
FRBN Forbion European Acquisition Corp. Director Dec 9, 2021

Insider Transactions Reported by Philip Astley-Sparke:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.